Orly Weinreb i
Dr. Orly Weinreb is a leading neuroscientist and researcher, who took a major part in the research and development of Rasagiline (Azilect®) at the Eve Topf Center Technion, IL. She earned a BSc (hon.), MSc and DSc at Technion – Israel Institute of Technology, Haifa and is a Postdoctoral European Common fellow, Netherlands. She is currently CEO at Glaucopharm Ltd and a co-founder of N2B Ltd.